Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.medicointercontinental.com | |
Market Cap | 94.70 Cr. | |
Enterprise Value(EV) | 100.53 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 3.78 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 25.07 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 74.87 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 42.98 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 2.20 | Calculated using Price: 94.70 |
Dividend Yield | 0.11 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.00 Cr. | 10,000,000 Shares |
FaceValue | 10 | |
About Medico Intercontinental Ltd. | ||
Medico Intercontinental Limited formerly Intercontinental Leasing & Finance Company Limited was incorporated on August 14, 1984. The Company is into the business of trading various medicines. The company also provides a platform to all research based biopharmaceutical companies reaching their Novel and innovative therapies. |
1 Day |
|
-1.06% |
1 Week |
|
-0.34% |
1 Month |
|
+2.45% |
3 Month |
|
+18.40% |
6 Month |
|
+27.10% |
1 Year |
|
+27.22% |
2 Year |
|
+148.54% |
5 Year |
|
+197.46% |
10 Year |
|
6 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 0.90 | 20.24 | 45.48 | 32.41 | 27.96 | 13.41 | |
Return on Capital Employed (%) | 1.41 | 28.42 | 36.08 | 25.00 | 25.69 | 16.57 | |
Return on Assets (%) | 0.76 | 11.32 | 10.44 | 7.73 | 9.91 | 7.95 |
Particulars | 7 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 3 | 4 | 6 | 10 | 13 | 41 | 43 | |
Non Curr. Liab. | 0 | 13 | 7 | 6 | 2 | 3 | ||
Curr. Liab. | 1 | 5 | 17 | 15 | 13 | 15 | 11 | |
Minority Int. | ||||||||
Equity & Liab. | 4 | 9 | 36 | 31 | 32 | 59 | 57 | |
Non Curr. Assets | 2 | 1 | 2 | 3 | 4 | 9 | 15 | |
Curr. Assets | 2 | 8 | 34 | 28 | 28 | 50 | 42 | |
Misc. Exp. not W/O | ||||||||
Total Assets | 4 | 9 | 36 | 31 | 32 | 59 | 57 |
Particulars | 7 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 10 | 82 | 70 | 74 | 76 | 88 | ||
Other Income | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |
Total Income | 0 | 10 | 82 | 70 | 75 | 77 | 89 | |
Total Expenditure | 0 | -9 | -78 | -65 | -69 | -71 | -83 | |
PBIDT | 0 | 1 | 4 | 5 | 5 | 6 | 6 | |
Interest | 0 | -1 | -1 | -1 | -1 | 0 | ||
Depreciation | 0 | 0 | 0 | 0 | 0 | |||
Taxation | 0 | 0 | -1 | -1 | -1 | -1 | -1 | |
Exceptional Items | ||||||||
PAT | 0 | 1 | 2 | 3 | 3 | 4 | 4 | |
Minority Interest | ||||||||
Share Associate | ||||||||
Other Related Items | ||||||||
Consolidated Net Profit | 0 | 1 | 2 | 3 | 3 | 4 | 4 | |
Adjusted EPS | 0 | 2 | 7 | 8 | 10 | 4 | 4 |
Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 1 | -14 | 6 | 4 | -10 | |
Cash Fr. Inv. | -4 | -1 | -1 | -5 | |||
Cash Fr. Finan. | 0 | 17 | -5 | -1 | 20 | ||
Net Change | 0 | 1 | 0 | 0 | 1 | 5 | |
Cash & Cash Eqvt | 0 | 1 | 1 | 1 | 2 | 7 |
Tue, 28 Nov 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Samir Dilipkumar Shah |
Sat, 25 Nov 2023
Submission Of Disclosure Under Regulation 7(2) Read With Regulation 6(2) Of SEBI (Prohibition Of Insider Trading) Regulations 2015. The Company has received disclosure dated 24th November 2023 under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations 2015 from Mr. Samir D Shah Promoter and Managing Director of the Company. |
Fri, 24 Nov 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Samir Dilipkumar Shah |
Mon, 04 Dec 2023 |
|
|
|
|
|